Literature DB >> 19909893

Antibiotics for gram-positive bacterial infections: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, dalbavancin, and telavancin.

Michael D Nailor1, Jack D Sobel.   

Abstract

An overview of the mechanism of action, dosing, clinical indications, and toxicities of the glycopeptide vancomycin is provided. The emerging gram-positive bacterial resistance to antimicrobials and its mechanisms are reviewed. Strategies to control this emergence of resistance are expected to be proposed. Newer antimicrobial agents that have activity against vancomycin-resistant organisms are now available and play a critical role in the treatment of life-threatening infections.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19909893     DOI： 10.1016/j.idc.2009.06.010

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN： 0891-5520            Impact factor:   5.982


  14 in total

Review 1.  Ménage à trois in the human gut: interactions between host, bacteria and phages.

Authors:  Mohammadali Khan Mirzaei; Corinne F Maurice
Journal:  Nat Rev Microbiol       Date:  2017-05-02       Impact factor: 60.633

2.  A comparison of different antibiotic regimens for the treatment of infective endocarditis.

Authors:  Arturo J Martí-Carvajal; Mark Dayer; Lucieni O Conterno; Alejandro G Gonzalez Garay; Cristina Elena Martí-Amarista
Journal:  Cochrane Database Syst Rev       Date:  2020-05-14

3.  Safety of intravitreal quinupristin/dalfopristin in an animal model.

Authors:  Veronica E Giordano; Sergio E Hernandez-Da Mota; Tania N Adabache-Guel; Armando Castillejos-Chevez; Sonia Corredor-Casas; Samantha M Salinas-Longoria; Rafael Romero-Vera; Juan M Jimenez-Sierra; Jose L Guerrero-Naranjo; Virgilio Morales-Canton
Journal:  Int J Ophthalmol       Date:  2016-03-18       Impact factor: 1.779

4.  New insights into the prevention of staphylococcal infections and toxic shock syndrome.

Authors:  Ying-Chi Lin; Marnie L Peterson
Journal:  Expert Rev Clin Pharmacol       Date:  2010-11-01       Impact factor: 5.045

5.  Pharmacodynamics of TD-1792, a novel glycopeptide-cephalosporin heterodimer antibiotic used against Gram-positive bacteria, in a neutropenic murine thigh model.

Authors:  Sharath S Hegde; Olanrewaju O Okusanya; Robert Skinner; Jeng-Pyng Shaw; Glenmar Obedencio; Paul G Ambrose; Johanne Blais; Sujata M Bhavnani
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

6.  A GC-MS-based untargeted metabolomics approach for comprehensive metabolic profiling of vancomycin-induced toxicity in mice.

Authors:  Changmeng Cui; Li Zhu; Qian Wang; Ruijuan Liu; Dadi Xie; Yujin Guo; Dingyi Yu; Changshui Wang; Dan Chen; Pei Jiang
Journal:  Heliyon       Date:  2022-07-06

Review 7.  Treatment considerations in vancomycin-resistant enterococcal bacteremia: daptomycin or linezolid? A review.

Authors:  Bhavarth S Shukla; Timothy P Gauthier; Ricardo Correa; Laura Smith; Lilian Abbo
Journal:  Int J Clin Pharm       Date:  2013-07-27

Review 8.  Endophthalmitis caused by Gram-positive organisms with reduced vancomycin susceptibility: literature review and options for treatment.

Authors:  Nidhi Relhan; Thomas A Albini; Avinash Pathengay; Ajay E Kuriyan; Darlene Miller; Harry W Flynn
Journal:  Br J Ophthalmol       Date:  2015-12-23       Impact factor: 4.638

9.  Characterization of the antibiotic compound no. 70 produced by Streptomyces sp. IMV-70.

Authors:  Lyudmila P Trenozhnikova; Almagul K Khasenova; Assya S Balgimbaeva; Galina B Fedorova; Genrikh S Katrukha; Nina L Tokareva; Boo H Kwa; Azliyati Azizan
Journal:  ScientificWorldJournal       Date:  2012-03-12

10.  The potential risk factors of nephrotoxicity during vancomycin therapy in Chinese adult patients.

Authors:  Yulin Wang; Jian Yang; Haiyan Zhan; Shuxiao Zhang; Yin Deng
Journal:  Eur J Hosp Pharm       Date:  2020-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.